Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparing harm reduction and overdose response services between community-based and public health department syringe service programmes using a national cross-sectional survey.
Ray BR, Humphrey JL, Patel SV, Akiba CF, Bluthenthal RN, Tookes H, LaKosky PA, Wenger LD, Kral AH, Lambdin BH. Ray BR, et al. Among authors: lakosky pa. Lancet Reg Health Am. 2024 May 6;34:100757. doi: 10.1016/j.lana.2024.100757. eCollection 2024 Jun. Lancet Reg Health Am. 2024. PMID: 38745887 Free PMC article.
Funding and Delivery of Syringe Services Programs in the United States, 2022.
Facente SN, Humphrey JL, Akiba C, Patel SV, Wenger LD, Tookes H, Bluthenthal RN, LaKosky P, Prohaska S, Morris T, Kral AH, Lambdin BH. Facente SN, et al. Among authors: lakosky p. Am J Public Health. 2024 Apr;114(4):435-443. doi: 10.2105/AJPH.2024.307583. Am J Public Health. 2024. PMID: 38478864 Free PMC article.
'New evidence' for Syringe Services Programs? A call for rigor and skepticism.
Lambdin BH, Bluthenthal RN, Humphrey JL, LaKosky P, Prohaska S, Kral AH. Lambdin BH, et al. Among authors: lakosky p. Int J Drug Policy. 2023 Nov;121:104107. doi: 10.1016/j.drugpo.2023.104107. Epub 2023 Aug 1. Int J Drug Policy. 2023. PMID: 37996217 Free article. No abstract available.
Availability of and Obstacles to Providing COVID-19 Vaccinations at Syringe Services Programs in the United States, 2021.
Des Jarlais DC, Behrends CN, Corcorran MA, Glick SN, Perlman DC, Kapadia SN, Lu X, Feelemyer J, LaKosky P, Prohaska SM, Schackman BR. Des Jarlais DC, et al. Among authors: lakosky p. Public Health Rep. 2022 Nov-Dec;137(6):1066-1069. doi: 10.1177/00333549221120241. Epub 2022 Sep 16. Public Health Rep. 2022. PMID: 36113105 Free PMC article.
Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives.
Austin EJ, Corcorran MA, Briggs ES, Frost MC, Behrends CN, Juarez AM, Frank ND, Healy E, Prohaska SM, LaKosky PA, Kapadia SN, Perlman DC, Schackman BR, Jarlais DCD, Williams EC, Glick SN. Austin EJ, et al. Among authors: lakosky pa. Int J Drug Policy. 2022 Nov;109:103825. doi: 10.1016/j.drugpo.2022.103825. Epub 2022 Aug 10. Int J Drug Policy. 2022. PMID: 35977459 Free PMC article.
Syringe Service Program Perspectives on Barriers, Readiness, and Programmatic Needs to Support Rollout of the COVID-19 Vaccine.
Corcorran MA, Austin EJ, Behrends CN, Briggs ES, Frost MC, Juarez AM, Frank ND, Healy E, Prohaska SM, LaKosky PA, Kapadia SN, Perlman DC, Schackman BR, Des Jarlais DC, Williams EC, Glick SN. Corcorran MA, et al. Among authors: lakosky pa. J Addict Med. 2023 Jan-Feb 01;17(1):e36-e41. doi: 10.1097/ADM.0000000000001036. Epub 2022 Aug 2. J Addict Med. 2023. PMID: 35916422 Free PMC article.
Responding to a surge in overdose deaths: perspectives from US syringe services programs.
Frost MC, Austin EJ, Corcorran MA, Briggs ES, Behrends CN, Juarez AM, Frank ND, Healy E, Prohaska SM, LaKosky PA, Kapadia SN, Perlman DC, Schackman BR, Des Jarlais DC, Williams EC, Glick SN. Frost MC, et al. Among authors: lakosky pa. Harm Reduct J. 2022 Jul 19;19(1):79. doi: 10.1186/s12954-022-00664-y. Harm Reduct J. 2022. PMID: 35854351 Free PMC article.
Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020.
Behrends CN, Lu X, Corry GJ, LaKosky P, Prohaska SM, Glick SN, Kapadia SN, Perlman DC, Schackman BR, Des Jarlais DC. Behrends CN, et al. Among authors: lakosky p. Drug Alcohol Depend. 2022 Mar 1;232:109323. doi: 10.1016/j.drugalcdep.2022.109323. Epub 2022 Jan 20. Drug Alcohol Depend. 2022. PMID: 35124386 Free PMC article.
14 results